Universidad Complutense de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2020

  1. Glucose metabolism links astroglial mitochondria to cannabinoid effects

    Nature, Vol. 583, Núm. 7817, pp. 603-608

2019

  1. Cannabidiol administration prevents hypoxia-ischemia-induced hypomyelination in newborn rats

    Frontiers in Pharmacology, Vol. 10, Núm. SEP

2017

  1. 2-arachidonoylglycerol reduces proteoglycans and enhances remyelination in a progressive model of demyelination

    Journal of Neuroscience, Vol. 37, Núm. 35, pp. 8385-8398

2016

  1. A cannabinoid link between mitochondria and memory

    Nature, Vol. 539, Núm. 7630, pp. 555-559

2014

  1. A restricted population of CB1 cannabinoid receptors with neuroprotective activity

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 22, pp. 8257-8262

  2. Cannabinoid type-1 receptors in the paraventricular nucleus of the hypothalamus inhibit stimulated food intake

    Neuroscience, Vol. 263, pp. 46-53

  3. New insights on food intake control by olfactory processes: The emerging role of the endocannabinoid system

    Molecular and Cellular Endocrinology, Vol. 397, Núm. 1-2, pp. 59-66

  4. The endocannabinoid system controls food intake via olfactory processes

    Nature Neuroscience, Vol. 17, Núm. 3, pp. 407-415

2013

  1. Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 12, pp. 4786-4791

2012

  1. Mitochondrial CB 1 receptors regulate neuronal energy metabolism

    Nature Neuroscience, Vol. 15, Núm. 4, pp. 558-564

2002

  1. Design, synthesis and pharmacological evaluation of 5-hydroxytryptamine1a receptor ligands to explore the three-dimensional structure of the receptor

    Molecular Pharmacology, Vol. 62, Núm. 1, pp. 15-21